January 8, 2015 · STOCK Act disclosure
Representative Tom Price (Republican-GA) bought Innate Immunotherapeutics, a stock transaction, valued at $1,000 - $15,000. The trade took place on January 8, 2015 and was disclosed on February 10, 2015 (owner: Joint/DC). Members of Congress must report such transactions within 45 days under the STOCK Act.